Last reviewed · How we verify
Urge urinary incontinence
Approved treatments
- Nuceiva · GlaxoSmithKline K.K.
Nuceiva works by blocking the release of acetylcholine, a neurotransmitter that transmits signals from nerve cells to muscles, thereby reducing muscle spasms and contractions.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Urge urinary incontinence patent landscape — cliff calendar, originator estates, attackable patents
- Urge urinary incontinence treatment landscape brief
- Urge urinary incontinence treatment updates RSS
Frequently asked questions about Urge urinary incontinence
What drugs treat Urge urinary incontinence?
Tracked treatments include Nuceiva.
What is the treatment for Urge urinary incontinence?
Standard treatment for Urge urinary incontinence includes Nuceiva. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Urge urinary incontinence patent cliff · Urge urinary incontinence CI report
- Treatment: Nuceiva · GlaxoSmithKline K.K.
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing